Inner Mongolia Glint Pharmaceutical Co., Ltd. – FDA Inspection, Mar 27, 2025

Record Details

This FDA Inspection record concerns Inner Mongolia Glint Pharmaceutical Co., Ltd., with an inspection on March 27, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Inner Mongolia Glint Pharmaceutical Co., Ltd.
Inspection Date: March 27, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Carolina D. Vasquez

View Company Profile

ID · b5375e9a-f496-4a7b-874d-85b46273b8d4

Inspection Facts

Inspection number: 1269229
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Inner Mongolia Glint Pharmaceutical Co., Ltd.

FDA Inspection

Inner Mongolia Glint Pharmaceutical Co., Ltd.March 27, 2025

Inner Mongolia Glint Pharmaceutical Co., Ltd. – FDA Inspection, Mar 27, 2025

Record Details

This FDA Inspection record concerns Inner Mongolia Glint Pharmaceutical Co., Ltd., with an inspection on March 27, 2025, issued by the Office of Inspections and Investigations, covering human drugs.